Relationship between obstructive sleep apnea and markers of cardiovascular alterations in never-treated hypertensive patients-Reference-Cited by-同舟云学术

Relationship between obstructive sleep apnea and markers of cardiovascular alterations in never-treated hypertensive patients

Published:2014-03-13 Issue:6 Volume:37 Page:573-579
ISSN:0916-9636
Container-title:Hypertension Research
language:en
Short-container-title:Hypertens Res

Author:

Prejbisz Aleksander,Florczak Elżbieta,Pręgowska-Chwała Barbara,Klisiewicz Anna,Kuśmierczyk-Droszcz Beata,Zieliński Tomasz,Makowiecka-Cieśla Magdalena,Kołodziejczyk-Kruk Sylwia,Śliwiński Paweł,Januszewicz Andrzej

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Physiology,Internal Medicine

Link

http://www.nature.com/articles/hr201443.pdf

Reference38 articles.

1. Kasai T, Floras JS, Bradley TD . Sleep apnea and cardiovascular disease: a bidirectional relationship. Circulation 2012; 126: 1495–1510.

2. Somers VK, White DP, Amin R, Abraham WT, Costa F, Culebras A, Daniels S, Floras JS, Hunt CE, Olson LJ, Pickering TG, Russell R, Woo M, Young T . Sleep apnea and cardiovascular disease: an American Heart Association/American College Of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council On Cardiovascular Nursing. In collaboration with the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health). Circulation 2008; 118: 1080–1111.

3. Parati G, Lombardi C, Hedner J, Bonsignore MR, Grote L, Tkacova R, Levy P, Riha R, Bassetti C, Narkiewicz K, Mancia G, McNicholas WT . Position paper on the management of patients with obstructive sleep apnea and hypertension: joint recommendations by the European Society of Hypertension, by the European Respiratory Society and by the members of European COST (COoperation in Scientific and Technological research) ACTION B26 on obstructive sleep apnea. J Hypertens 2012; 30: 633–646.

4. Jozwik-Plebanek K, Prejbisz A, Janaszek-Sitkowska H, Klisiewicz A, Sliwinski P, Pregowska-Chwala B, Hoffman P, Januszewicz A . Obstructive sleep apnea and cardio-vascular damage. Kardiol Pol 2012; 70: 735–740.

5. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, Schmieder RE, Boudier HA, Zanchetti A . 2007 Guidelines for the Management of Arterial Hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007; 25: 1105–1187.

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of sleep characteristics with renal function in menopausal women without recognized chronic kidney disease;Frontiers in Psychiatry;2022-11-09

2. Is myocardial strain an early marker of systolic dysfunction in obstructive sleep apnoea? Findings from a meta-analysis of echocardiographic studies;Journal of Hypertension;2022-08

3. Obstructive sleep apnoea and left ventricular diastolic dysfunction among first responders to the 9/11 World Trade Center terrorist attack: a cross-sectional study;BMJ Open;2022-04

4. Is kidney a new organ target in patients with obstructive sleep apnea? Research priorities in a rapidly evolving field;Sleep Medicine;2021-10

5. Obstructive Sleep Apnea–Induced Neurogenic Nocturnal Hypertension;Hypertension;2021-04